Nutrien Ltd (NTR)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NYSE
Market Cap: $33.78B
Last updated: Nov 17, 2026 at 11:06 AM ET
Nutrien Ltd (NTR) Stock Forecast
Analysts expect Nutrien (NTR) to earn $4.71 per share in the fiscal year ending Dec 31, 2026, on revenue of $27.63B. Of 26 analysts, 15 rate the stock Buy or Strong Buy, 9 Hold and 2 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 4 estimates for the fiscal year ending Dec 31, 2026 were revised up and 8 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 26 ratings average 2.23, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 58% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 7 | 26.9% |
| Buy | 8 | 30.8% |
| Hold | 9 | 34.6% |
| Sell | 2 | 7.7% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 26
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 8.5% and revenue estimates fall 1.1%.
- Fiscal year ending Dec 31, 2026
- $4.71
- EPS consensus, revenue $27.63B
- Fiscal year ending Dec 31, 2027
- $5.11
- EPS consensus, revenue $27.32B
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.71 | $4.34 to $5.35 | 21 | $27.63B | $27.36B to $28.20B | 13 |
| Dec 31, 2027 | $5.11 | $3.66 to $6.72 | 23 | $27.32B | $26.57B to $28.80B | 13 |
Quarterly Estimates
The EPS consensus falls from $0.99 for the quarter ending Dec 31, 2026 to $0.67 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.99 | $0.80 to $1.19 | 19 | $5.44B | $5.17B to $5.77B | 15 |
| Mar 31, 2027 | $0.67 | $0.36 to $0.89 | 7 | $5.80B | $5.67B to $5.93B | 2 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 12 upward and 12 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 4 | 8 |
| Fiscal year ending Dec 31, 2027 | 8 | 4 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 5.6% from $4.99.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $4.71 | $5.01 | $4.97 | $4.97 | $4.99 | -5.6% |
| Fiscal year ending Dec 31, 2027 | $5.11 | $5.08 | $5.03 | $4.95 | $4.90 | +4.1% |
| Quarter ending Mar 31, 2027 | $0.67 | $0.71 | $0.76 | $0.77 | $0.77 | -14.0% |
Frequently Asked Questions About NTR
What is the NTR stock forecast?
Consensus analyst estimates put Nutrien's EPS at $4.71 for the fiscal year ending Dec 31, 2026, on revenue of $27.63B. The consensus rating from 26 analysts is Buy.
How do analysts rate NTR stock?
Of 26 analysts covering Nutrien, 7 rate it Strong Buy, 8 Buy, 9 Hold, 2 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from NTR next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.71, with estimates from $4.34 to $5.35 from 21 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $5.11, with estimates from $3.66 to $6.72 from 23 analysts.
What revenue do analysts expect from Nutrien next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $27.63B, with estimates from $27.36B to $28.20B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $27.32B, with estimates from $26.57B to $28.80B.
How many analysts cover NTR?
26 analysts rate Nutrien stock, and 21 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
NTR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts